Cell surface azide groups (N3)

Cell surface azide groups are synthetic chemical handles introduced onto the plasma membrane of specific cell types, such as neural progenitor cells and astrocytes, through metabolic glycoengineering (Laughlin et al., 2007, Science). This process involves feeding cells unnatural sugar precursors, such as N-azidoacetylmannosamine (ManNAz), which are incorporated into the glycan chains of cell surface proteins and lipids by the cell's endogenous biosynthetic machinery (Prescher & Bertozzi, 2005, Nature Chemical Biology). Once expressed on the cell surface, these azide groups act as unique chemical tags that are absent from natural biological systems, providing a high degree of specificity for bioorthogonal reactions. They are primarily targeted using click chemistry reagents, such as dibenzocyclooctyne (DBCO) or bicyclononyne (BCN), which react with the azide via strain-promoted azide-alkyne cycloaddition (SPAAC) without requiring toxic catalysts (Agard et al., 2004, JACS). This targeting strategy is utilized in research and drug development to deliver imaging agents, nanoparticles, or therapeutic payloads directly to labeled cells in the brain or other tissues (Xie et al., 2016, PNAS). While not an endogenous receptor, these groups function as artificial receptors for therapeutic and diagnostic applications in neurobiology and regenerative medicine.

Other names

Azide-modified glycansBioorthogonal azide handlesMetabolically labeled cell surface azidesAzido-glycansMetabolically incorporated azides

Strain-promoted azide-alkyne cycloaddition (SPAAC), Copper-catalyzed azide-alkyne cycloaddition (CuAAC), Staudinger ligation